Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01039584 · ClinicalTrials.gov registry record · NA
A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% Formulations
A NA study, sponsored by Padagis.
- Completed
- Registry status
- NA
- Development phase
- 611
- Enrollment target
NCT01039584 is a NA study that has completed, run by Padagis. The registered enrollment target is 611 participants.
The verdict
NCT01039584, a NA study, has completed, sponsored by Padagis.
- COMPLETED
- Registry status
- NA
- Development phase
- 611 participants
- Enrollment target
Study Summary
This was a study that compared the efficacy and safety of a generic butoconazole nitrate vaginal cream, 2% to Gynazole-1 (butoconazole nitrate) Vaginal Cream, 2% in the treatment of vulvovaginal candidiasis caused by Candida species.
Interventions
- DRUG Placebo
- DRUG Butoconazole Nitrate Vaginal Cream
- DRUG Gynazole 1 vaginal cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 611 participants |
| Start Date | 2008-02 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01039584
The ClinicalTrials.gov registry entry for NCT01039584 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 611 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Padagis, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01039584 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01039584 about?
NCT01039584 is a clinical study titled "A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% Formulations". This was a study that compared the efficacy and safety of a generic butoconazole nitrate vaginal cream, 2% to Gynazole-1 (butoconazole nitrate) Vaginal Cream, 2% in the treatment of vulvovaginal candidiasis caused by Candida species.
What is the current status of trial NCT01039584?
This trial is currently completed. It is a NA study. The enrollment target is 611 participants. The study started on 2008-02. Estimated completion is 2009-12.
What interventions are being tested in trial NCT01039584?
The interventions under investigation include: Placebo (DRUG), Butoconazole Nitrate Vaginal Cream (DRUG), Gynazole 1 vaginal cream (DRUG).
Who is sponsoring clinical trial NCT01039584?
This trial is sponsored by Padagis, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.